The global transcranial magnetic stimulator market has been gaining significant traction over the recent past due to the growing prevalence and recurrence of neurological disorders such as depression, Parkinson’s disease and Alzheimer’s disease. Transcranial magnetic stimulation is a non-invasive technique used to stimulate small targeted areas of the brain and influence neural activity using electromagnetic induction. The device employs a magnetic coil which is placed near the head of a person to pass electric current through the coil and generate a localized magnetic field. This magnetic field induces a small electric current in nearby brain tissue and stimulates the targeted region of the brain. It is used to treat neurological and psychiatric conditions by regulating neural activity using electromagnetic pulses.

The Global transcranial magnetic stimulator market is estimated to be valued at US$ 1.42 Bn in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the transcranial magnetic stimulator market are Medtronic, Liva Nova PLC, Dextera Surgical Inc., Ethicon US, LLC., Synovis Micro Alliance, Inc., Vitalitec International Inc., and MAQUET Holding B. V. & Co. KG., among others. The rising prevalence of depression and other mental health disorders across the globe has fueled the demand for innovative treatment methods like Transcranial Magnetic Stimulator Market Size . Transcranial magnetic stimulation provides a non-invasive approach for treatment and is free from side effects associated with medications, hence its adoption has significantly increased in recent years. The major players in the market are focusing on geographic expansion and strengthening their distribution networks in emerging markets to tap the growth opportunities in these regions.

Gets More Insights on: Transcranial Magnetic Stimulator Market